Aegros set to move on to CSL’s plasma turf
MELBOURNE: It’s been a 30-plus year journey for small plasma fractionation biotech Aegros, but the
MELBOURNE: It’s been a 30-plus year journey for small plasma fractionation biotech Aegros, but the